Detalhe da pesquisa
1.
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
N Engl J Med
; 388(10): 873-887, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808186
2.
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
Clin Infect Dis
; 78(3): 514-517, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879092
3.
Long-Term Protective Effect of Tuberculosis Preventive Therapy in a Medium/High Tuberculosis Incidence Setting.
Clin Infect Dis
; 78(5): 1321-1327, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407417
4.
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis.
Antimicrob Agents Chemother
; 68(5): e0158323, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597667
5.
Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection.
J Antimicrob Chemother
; 79(6): 1270-1278, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661209
6.
Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia.
J Antimicrob Chemother
; 79(5): 977-986, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459759
7.
Completion of isoniazid preventive therapy for latent tuberculosis infection among children and adolescents compared to adults living with HIV in Kinshasa, Democratic Republic of the Congo.
Trop Med Int Health
; 29(2): 88-95, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123460
8.
A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.
Eur J Clin Microbiol Infect Dis
; 43(1): 73-85, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943394
9.
Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study.
Eur J Clin Microbiol Infect Dis
; 43(5): 809-820, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383889
10.
Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients.
Infection
; 52(3): 1055-1061, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347366
11.
Cost-effectiveness of interferon-γ release assay for screening of latent tuberculosis infection in individuals with schizophrenia.
Epidemiol Infect
; 152: e13, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38178725
12.
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis.
BMC Infect Dis
; 24(1): 7, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166793
13.
Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019-2021.
BMC Infect Dis
; 24(1): 511, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773443
14.
Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
BMC Infect Dis
; 24(1): 499, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760665
15.
Development of a multiplex droplet digital PCR method for detection and monitoring of Mycobacterium tuberculosis and drug-resistant tuberculosis.
Ann Clin Microbiol Antimicrob
; 23(1): 29, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581051
16.
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Am J Respir Crit Care Med
; 207(7): 929-935, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455068
17.
Mid-level managers' perspectives on implementing isoniazid preventive therapy for people living with HIV in Ugandan health districts: a qualitative study.
BMC Health Serv Res
; 24(1): 313, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454501
18.
Current Status of Latent Tuberculosis Infection Treatment Among Pediatric Patients in Korea: Prescription and Treatment Completion.
J Korean Med Sci
; 39(7): e64, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412611
19.
Application of the Hollow-Fiber Infection Model to Personalized Precision Dosing of Isoniazid in a Clinical Setting.
J Korean Med Sci
; 39(13): e104, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599596
20.
The Changing Paradigm of Drug-Resistant Tuberculosis Treatment: Successes, Pitfalls, and Future Perspectives.
Clin Microbiol Rev
; 35(4): e0018019, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200885